Accessibility Menu
MedWellAI logo

MedWellAI(OTC) INTV

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-100%
5 Year-99%
1 Year-42%
1 Month+21%
N/A
MedWellAI last closing stock price
MetricPriceDate
Last closeUSD 0.352026-07-30
MedWellAI stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.43%USD 0.372026-07-23
1 month+20.83%USD 0.292026-06-30
3 month-10.08%USD 0.392026-05-01
Year to date-30.39%USD 0.502025-12-31
1 year-42.1%USD 0.602025-07-30
3 year-87.57%USD 2.802023-07-31
5 year-98.64%USD 25.502021-07-30
Since inception-99.99%USD 6,937.502015-05-28

MedWellAI Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.86M

Net Income (TTM)

-$2.31M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

May 16, 2025

INTV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MedWellAI

MedWellAI helps clinics and wellness centers order medicines and manage supplies. Its platform uses artificial intelligence to suggest products and track inventory. The company also manages real estate for healthcare providers.

What’s in the MedWellAI Toolbox?

  • Pharmaceutical Distribution (95.3% of revenue for the three months ended December 31, 2025): Bulk sales of weight loss and diabetes medicines to clinics and doctors’ offices.
  • B2B E-commerce Platform: Online ordering system with AI-powered inventory tracking and product suggestions for healthcare providers.
  • Facilities Management: Real estate development and sub-leasing for wellness clinics and healthcare operators.
  • Support Services: Assistance for med spas, wellness clinics, and corporate wellness facilities using the platform.
  • Rental Income: Earnings from sub-leased properties to healthcare businesses.

Growth Moves: MedWellAI’s Expansion Playbook

  • Acquired 51% of Healthy Lifestyle USA LLC in August 2024, shifting focus to healthcare.
  • Exited digital asset mining in June 2024 to concentrate on wellness and pharmaceuticals.
  • Launched AI-powered B2B e-commerce platform for pharmaceutical distribution in 2025.
  • Entered real estate development and sub-leasing for healthcare providers in June 2025.
  • Consolidated preferred stock classes in August 2025 to simplify capital structure.

Why MedWellAI Stands Out (Without the Hype)

MedWellAI combines pharmaceutical distribution with real estate management for healthcare clients. Its AI-driven ordering system helps clinics manage supplies efficiently. The company’s business model targets both product delivery and facility support for wellness providers.

Five Things You Need to Know

  • Revenue was $96,094 in QQ1 2026, up 8,270.6% from QQ1 2025.
  • Pharmaceutical distribution made up 95.9% of revenue in the latest quarter.
  • Net loss was $326,034 in QQ1 2026, improving 72.2% year-over-year.
  • Cash at December 31, 2025, was $137,503, with a $7.5 million working capital deficit.
  • Company has one full-time employee and relies on raising new capital.

Bottom Line

MedWellAI has shifted from digital assets to healthcare, focusing on AI-driven distribution and real estate for clinics. The company faces financial challenges but continues to adapt its business model.

AI Generated • Apr 16, 2026

Industry

Software

Employees

1

CEO

Steve Rubakh

Headquarters

Tioga, PA 19006, US

INTV Financials

Key Financial Metrics (TTM)

Gross Margin

81.64%

Operating Margin

-233.45%

Net Income Margin

-433.22%

Return on Equity

47.04%

Return on Capital

N/A

Return on Assets

-430.84%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$606.19K

Operating Income

-$765.20K

EBITDA

-$1.41M

Operating Cash Flow

-$366.37K

Capital Expenditure

$91.90K

Free Cash Flow

-$274.46K

Cash & ST Invst.

$130.03K

Total Debt

$592.48K

MedWellAI Performance Analysis

MedWellAI annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 4,871,473N/A
20232023-06-30USD 3,862,849-20.7%
20242024-06-30USD 0N/A
20252025-06-30USD 594,768N/A
MedWellAI sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30-39.8%
Q12025-09-30-43.3%
Q22025-12-31919.5%
Q32026-03-31-36.9%
MedWellAI annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD -0.68N/A
20232023-06-30USD -11.981658.3%
20242024-06-30USD -2.72-77.3%
20252025-06-30USD -0.63-76.8%
MedWellAI sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3060.4%
Q12025-09-30-129.6%
Q22025-12-3144.4%
Q32026-03-3120.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$618.68K

+119.9%

Gross Profit

$152.67K

-45.1%

Gross Margin

24.68%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

1

N/A

Net Income

-$240.24K

+59.2%

EBITDA

-$244.82K

+40.3%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$130.03K

-73.0%

Total Debt

$592.48K

-2.2%

Accounts Receivable

$2.94K

-97.8%

Inventory

$0.00

N/A

Long Term Debt

$61.13K

-25.1%

Short Term Debt

$531.35K

+1.4%

Return on Assets

-4.31%

N/A

Return on Invested Capital

18.28%

N/A

Free Cash Flow

$0.00

+100.0%

Operating Cash Flow

$0.00

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EICCFE Automotive Inc.
$0.01+0.00%
RAYTRayont Inc.
$0.03+0.00%
BOMObowmo, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$26.97+0.37%
NOKNokia
$9.09+0.08%
SKHYSK Hynix
$149.00+0.18%
TQQQProShares Trust - ProShares UltraPro Qqq
$63.30+0.10%

Questions About INTV

What is the current price of MedWellAI?

MedWellAI is trading at N/A per share.

What is the 52-week range for MedWellAI?

Over the past 52 weeks, MedWellAI has traded between N/A and N/A.

How much debt does MedWellAI have?

As of the most recent reporting period, MedWellAI reported total debt of $7.09M.

How much cash does MedWellAI have on hand?

MedWellAI reported $130.03K in cash and cash equivalents in its most recent financial results.

What is MedWellAI’s dividend yield?

MedWellAI does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.